Skip to Content
  • Previous Rank
    66
  • Revenues ($M)
    $48,572.00
  • Revenue Percent Change
    19.3%
  • Profits ($M)
    $828
  • Profits Percent Change
    47.3%
  • Assets ($M)
    $21,855.00
  • Employees
    33,700
  • Market Value — as of March 29, 2018 ($M)
    $18,703.50

Centene is a bit of an outlier among its health insurance peers. While the past few years have produced a cascade of insurer exits from Obamacare’s marketplaces — particularly amid uncertainty about the health law’s future and the Trump administration’s thousand cuts to the program — Centene has doubled down. And it’s paid off in spades. More than 1.4 million Americans signed up for Centene’s federal Affordable Care Act plans during the most recent open enrollment season, leading CEO Michael Neidorff to exclaim the firm “had planned on incremental growth, but not that much.” The company also has a growing footprint in the managed care market fueled by deals such as its $3.75 billion acquisition of Fidelis Care last fall.

Company Info

CEO
Michael F. Neidorff
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Health Care: Insurance and Managed Care
HQ Location
St. Louis
Websitehttp://www.centene.com
Years on Fortune 500 List9
Employees33,700
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Centene Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$48,572.0019.3%
Profits ($M)$82847.3%
Assets ($M)$21,855.00-
Total Stockholder Equity ($M)$6,850.00-
Market Value — as of March 29, 2018 ($M)$18,703.50-

Profit Ratios

Profit as % of Revenues1.7%
Profits as % of Assets3.8%
Profits as % of Stockholder Equity12.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)4.69
EPS % Change (from 2016)36.7%
EPS % Change (5 year annual rate)215.5%
EPS % Change (10 year annual rate)19.1%

Total Return

Total Return to Investors (2017)78.5%
Total Return to Investors (5 year, annualized)37.5%
Total Return to Investors (10 year, annualized)22.1%